Your browser doesn't support javascript.
loading
Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants.
Saluja, Tarun; Rai, Ganesh Kumar; Chaudhary, Shipra; Kanodia, Piush; Giri, Bishnu Rath; Kim, Deok Ryun; Yang, Jae Seung; Park, Il-Yeon; Kyung, Seung-Eun; Vemula, Sridhar; Reddy E, Jagadeesh; Kim, Bomi; Gupta, Birendra Prasad; Jo, Sue Kyoung; Ryu, Ji Hwa; Park, Ho Keun; Shin, Jong Hoon; Lee, Yoonyeong; Kim, Hun; Kim, Jerome H; Mojares, Zenaida Reynoso; Wartel, T Anh; Sahastrabuddhe, Sushant.
Afiliación
  • Saluja T; International Vaccine Institute, Seoul, Republic of Korea. Electronic address: Tarun.Saluja@ivi.int.
  • Rai GK; Kanti Children's Hospital, Kathmandu, Nepal.
  • Chaudhary S; B P Koirala Institute of Health Sciences, Dharan, Nepal.
  • Kanodia P; Nepalgunj Medical College, Nepalgunj, Nepal.
  • Giri BR; Kanti Children's Hospital, Kathmandu, Nepal.
  • Kim DR; International Vaccine Institute, Seoul, Republic of Korea.
  • Yang JS; International Vaccine Institute, Seoul, Republic of Korea.
  • Park IY; International Vaccine Institute, Seoul, Republic of Korea.
  • Kyung SE; International Vaccine Institute, Seoul, Republic of Korea.
  • Vemula S; International Vaccine Institute, Seoul, Republic of Korea.
  • Reddy E J; International Vaccine Institute, Seoul, Republic of Korea.
  • Kim B; International Vaccine Institute, Seoul, Republic of Korea.
  • Gupta BP; International Vaccine Institute, Seoul, Republic of Korea.
  • Jo SK; International Vaccine Institute, Seoul, Republic of Korea.
  • Ryu JH; SK bioscience, Seoul, Republic of Korea.
  • Park HK; SK bioscience, Seoul, Republic of Korea.
  • Shin JH; SK bioscience, Seoul, Republic of Korea.
  • Lee Y; SK bioscience, Seoul, Republic of Korea.
  • Kim H; SK bioscience, Seoul, Republic of Korea.
  • Kim JH; International Vaccine Institute, Seoul, Republic of Korea.
  • Mojares ZR; International Vaccine Institute, Seoul, Republic of Korea.
  • Wartel TA; International Vaccine Institute, Seoul, Republic of Korea.
  • Sahastrabuddhe S; International Vaccine Institute, Seoul, Republic of Korea.
Vaccine ; 40(40): 5828-5834, 2022 09 22.
Article en En | MEDLINE | ID: mdl-36064672
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Fiebre Tifoidea / Vacunas Tifoides-Paratifoides / Sarampión / Paperas Tipo de estudio: Clinical_trials / Guideline Límite: Child / Child, preschool / Humans / Infant País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Fiebre Tifoidea / Vacunas Tifoides-Paratifoides / Sarampión / Paperas Tipo de estudio: Clinical_trials / Guideline Límite: Child / Child, preschool / Humans / Infant País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos